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High plasma renin activity is combined with elevated urinary available, Ang II receptor antagonists seem to possess
albumin excretion in essential hypertensive patients. similar renoprotective properties [10–12].
Background. Several studies suggest that the hyperactivity Both animal [13–15] and human studies [9, 10] haveof the circulating renin-angiotensin system might favor the
shown that the renal effects of ACE inhibitors are dueprogression of renal disease in essential hypertension. To eluci-
to decreased Ang II formation rather than increaseddate this aspect, we investigated the relationship between
plasma renin activity (PRA) and the urinary albumin excretion bradikinin breakdown. Accordingly, a small comparative
rate (UAER), an early marker of hypertension-related renal study showed that the Ang II receptor antagonist losar-
changes, in human essential hypertension. tan and the ACE inhibitor enalapril exerted similar renalMethods. Ninety nonobese, nondiabetic, nonhyperlipidemic
hemodynamic and antiproteinuric effects [10]. Thus, thepatients with mild-to-moderate essential hypertension (67
activity of the renin system seems to be deeply involvedmales, 23 females; mean age 51.4 6 6.2 years) were divided
into low renin (LR), normal renin (NR), and high renin (HR) in the development of renal damage and to promote the
subgroups according to individual PRA while they were on a appearance of proteinuria. In this context, overt protein-
constant NaCl intake (120 mmol NaCl/day). The UAER was
uria, that is, a protein excretion of more than 200 mg/min,assessed during the same NaCl intake.
is known to be preceded by microalbuminuria, a proteinResults. Data showed significantly higher UAER (31.3 6
12.9 mg/min) in HR (N 5 30) than NR (N 5 30, 22.7 6 14.4 excretion of more than 20 mg/min but less than 200 mg/min
mg/min, P , 0.02) and LR patients (N 5 30, 21.7 6 10.8 mg/ [2, 16]. Microalbuminuria is a well-recognized predictor
min, P , 0.01). of the decline of renal function in both insulin- and, to a
Conclusions. Our study demonstrates that the UAER is ele-
lesser extent, non-insulin-dependent diabetes (NIDDM)vated in HR essential hypertensive patients, suggesting that
[17, 18]. Regarding essential hypertension, few data arehigh PRA accelerates the onset of early renal changes in human
essential hypertension. currently available to support microalbuminuria is a pre-
dictor of renal insufficiency [17]. Indeed, the vast major-
ity of studies have been conducted in patients with overt
Angiotensin II (Ang II) is generally believed to favor proteinuria and/or markedly decreased renal function
the progression of hypertension-related renal damage [4, 8, 9, 19, 20]. Consequently, microalbuminuria is not
[1–5], and accordingly, Ang II infusion significantly in- generally accepted as a marker of progression of renal
creases intraglomerular pressure and fractional albumin damage in essential hypertension. In spite of this, one
excretion [6, 7]. By contrast, angiotensin-converting en- ongoing trial aiming to evaluate the prognostic value of
zyme (ACE) inhibitors exert a marked renoprotective microalbuminuria in nondiabetic hypertensives suggests
effect, that is, there is an increase of renal plasma flow a clear association between urinary albumin levels and
and a decrease of glomerular filtration fraction, protein- early renal changes [21]. Although the follow-up data
uria, microalbuminuria, and rate of decline of glomerular of this study are still unpublished, transversal analysis
filtration [2, 4, 6, 8, 9]. Although only preliminary data are confirmed the linkage between early changes in creati-
nine clearance and urinary albumin levels [21]. A retro-
spective analysis conducted in 141 hypertensives demon-Key words: hypertension, albuminuria, nephropathy, renin-angioten-
sin system. strated a significantly more rapid decline of creatinine
clearance in microalbuminuric (decrease of 12.1 6 2.77Received for publication August 7, 1998
ml/min over a mean period of seven years) than in nor-and in revised form April 26, 1999
Accepted for publication May 19, 1999 moalbuminuric patients (7.1 6 0.88 ml/min during the
same period) [22]. Furthermore, a large-scale trial re- 1999 by the International Society of Nephrology
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cently demonstrated that proteinuria is a good predictor position, on the last day of the three-week period on the
previously described diet (Fig. 1).of renal insufficiency in nondiabetic hypertensives [23].
Taken together, these findings suggest that microalbumi-
Laboratory methodsnuria possibly identifies at an early stage essential hyper-
Serum and urinary sodium, chloride, and potassiumtensive patients with an elevated risk of developing renal
were measured with a flame photometer and serum glu-hypertensive complications [24]. In spite of this, there
cose and creatinine with an autoanalyzer. PRA was as-are no studies on the possible relationship between
sessed by radioimmunassay (Sorin Biomedica, Vercelli,plasma renin activity (PRA) and the urinary albumin
Italy). To evaluate plasma Ang II without previous high-excretion rate (UAER) in essential hypertensives.
performance liquid chromatography [25], 1.5 ml of eachTo address this topic, the UAER was evaluated in a
patient’s plasma sample was mixed with 8 ml of chilledlarge population of essential hypertensive patients di-
ethanol (98%). Plasma was then mixed end over end atvided in low renin (LR), normal renin (NR), and high
48C over a period of 30 minutes. After this time, plasmarenin (NR) subgroups based on individual PRA while
was centrifuged at 1000 g for 20 minutes at 48C. Thethey were on a constant NaCl intake.
obtained supernatant was then decanted into a poly-
propylene tube located in a water bath at 378C, evaporat-
METHODS ing the ethanol to dryness with a stream of compressed
air. Following evaporation, the samples were dissolvedNinety-nine never-treated hypertensive outpatients
in 1.5 ml of Tris buffer (pH 7.4) and incubated with Angwere recruited in our outpatient unit and, after informed
II antibody and 125I-Ang II. The tubes were allowed toconsent, accepted to participate in this study. Inclusion
equilibrate for 24 hours at 48C. After this time, antibody-criteria were age between 40 and 65 years, a body mass
bound Ang II was separated from free Ang II by theindex of more than 20 and less than 27 kg/m2, normal
addition of 500 ml of ice-cold dextran-coated charcoal.fasting and postload (75 g oral glucose) glucose levels,
Both bound and free Ang II were counted, and the Angabsence of glycosuria, normal serum lipid levels, supine
II level of samples was obtained by extrapolation fromdiastolic and systolic blood pressure between 95 and 115
a standard curve. The albumin concentration in the urinemm Hg and 160 to 180 mm Hg at three different visits
was measured by nephelometry. During each visit in ourperformed at one-week intervals, serum creatinine of
outpatients unit the subject’s blood pressure and heartless than 110 mmol/liter, the absence of macroprotein-
rate were checked, that is, each week before the urineuria, and a negative culture of the first morning urine
collection for UAER measurements, each day of urinespot. Patients with concomitant diseases, “heavy” drink-
collection, and then the day after the last urine collection.ers, or smokers were excluded. Secondary forms of hy-
Blood pressure was measured by a standard Riva-Roccipertension were excluded by clinical and laboratory as-
sphygmomanometer (Zenith, Rome, Italy) and with asessments.
stethoscope placed over the brachial artery after the
patients rested for 10 minutes in a supine position inStudy design
a comfortable air-conditioned room (22 to 248C). As
After a period of three weeks during which the pre- recommended, a cuff of the appropriate size completely
viously mentioned entry criteria were evaluated (phase encircled the nondominant arm, which was supported at
A), all patients were given a weight-maintaining diet the heart level [26]. Systolic blood pressure was taken
containing about 1 g/kg protein, 2.5 g/kg carbohydrate, at Korotkoff’s Phase I, and diastolic blood pressure was
0.5 g/kg fat, 120 mmol NaCl, and 60 mmol K1 per day, taken at Korotkoff’s Phase V [26]. The first measurement
and they were invited to drink 2 liters of tap water per of blood pressure and heart rate was excluded, and the
day. On the last three days of a three-week period on average of the following three measurements taken at
this diet (phase B), patients were asked to collect 24- three-minute intervals was considered. Blood pressure
hour urine samples for measurements of the UAER, was measured by researchers who were unaware of the
electrolytes, and creatinine clearance (Fig. 1). To verify study purpose, design, and results.
a correct urine sampling, 24-hour urinary sodium and
Statistical analysischloride excretion were checked on all of the three urine
collections. Nine patients with sodium and chloride ex- All data were stored in a PC-compatible network and
cretion ,80 mmol/24 hr and/or .130 mmol/24 hr were were analyzed by the software Excel (Microsoft Inc.,
excluded from the study. In the remaining hypertensives Seattle, Washington, USA) loaded with the software
(N 5 90, 67 males and 23 females), fasting PRA and Primit (McGraw-Hill Co., New York, NY, USA 1995)
Ang II levels were evaluated at 8:00 a.m. in our outpa- and SPSS (SPSS, Chicago, IL, USA). Unless otherwise
tient unit. For this purpose, blood samples were taken stated, all data are presented as mean 6 sd. An individ-
ual UAER represents the mean of three consecutivefrom an antecubital vein after one hour in the supine
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Fig. 1. Study design. During the first period of three weeks (phase A), entry criteria (discussed in Methods section) were evaluated in consecutive
essential hypertensives outpatients, thereby allowing the selection of 99 nonobese, nondiabetic, nonmacroproteinuric hypertensives with diastolic-
systolic blood pressure levels between 95 and 115 and 140 to 160 mm Hg, respectively. These patients were given a weight-maintaining diet
containing a constant amount of NaCl (120 mol per day) and K1 (60 mmol per day; phase B). On the last three days (indicated as day 5, day 6,
and day 7) of a three-week period on this diet, patients brought 24-hour urine collections for urinary albumin, NaCl, K1, and creatinine measurements.
Blood samples for measurements of plasma renin activity (PRA) and angiotensin II (Ang II) levels were also drawn from each patient at the end
of the same diet, after one hour in a spine position. Nine patients who were uncompliant to the diet because of a NaCl excretion ,80 mmol/24
hr or .130 mmol/24 hr, were not considered. Thus, the study was completed in 90 patients.
measurements. Statistical significance was considered for (NR; N 5 30, 19 males, 11 females), and those with the
highest PRA values (HR; N 5 30, 26 males, 4 females;P values , 0.05. Differences among groups were tested
Table 1). UAER was significantly greater in the HRfor significance by one-way analysis of variance. The
(31.3 6 12.9 mg/min) than in the NR (22.7 6 14.4 mg/influence of all evaluated variables (PRA, Ang II, rou-
min, P , 0.02) and LR subgroups (21.7 6 10.8 mg/min,tine analysis, heart rate, blood pressure levels, body mass
P , 0.01; Fig. 2). By contrast, the UAER did not differindex, and body weight) on the UAER were tested by
between NR and LR patients.multivariate analysis. Linear regression analysis was per-
Considering a UAER of more than 20 mg/min as theformed to determine significant correlations between
cut-off value for defining a patient as microalbuminurictwo variables. The chi-square method was used for de-
[2, 16], the prevalence of microalbuminuria resulted sig-scriptive parameters.
nificantly higher in HR than NR and LR patients (P 5
0.02, HR vs. NR and LR). Because overt proteinuria, that
RESULTS is, an UAER of more than 200 mg/min, was considered to
The general characteristics of hypertensive patients be an exclusion criterion, none of the evaluated patients
are given in Table 1. Based on individual PRA (as mea- manifested proteinuria.
sured in supine position and at the end of a 3 week Multivariate analysis showed a significant influence of
period on a 120 mmol NaCl diet), hypertensive patients plasma Ang II levels on the UAER in HR patients.
were divided in tertiles, that is, those with the lowest (LR; Accordingly, the UAER correlated with circulating Ang
II concentrations (Fig. 3). Multivariate analysis alsoN 5 30, 22 males, 8 females), those with the intermediate
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Table 1. General characteristics of the study population
HR NR LR
(N 5 30) (N 5 30) (N 5 30)
PRA values ng/liter/second 0.63–4.5 0.29–0.62 0.10–0.28
Age years 52.166.6 51.966.3 50.366.3
Gender male/female 22/8 19/11 26/4
Systolic blood pressure mm Hg 170.164.0 168.065.8 166.565.1
Diastolic blood pressure mm Hg 99.765.3 99.264.8 98.664.7
Heart rate beats/min 74.464.2 72.965.3 74.063.7
Fasting glucose mmol/liter 4.960.9 4.860.5 4.860.3
Blood urea nitrogen mmol/liter 5.360.7 4.960.4 5.060.8
Serum creatinine lmol/liter 98.262.4 97.163.3 97.062.8
Urinary sodium mmol/24 hr 104.066.5 101.365.1 105.066.7
Data are mean 6 sd; plasma renin activity (PRA) values are given as range. Abbreviations are: HR, high renin patients; NR, normal renin patients; LR, low
renin patients.
Fig. 3. Direct relationship between urinary albumin excretion rate and
plasma angiotensin II levels in 30 essential hypertensive patients with
a high renin profile (P 5 0.018, r 5 0.430).Fig. 2. Individual urinary albumin excretion rate in 90 essential hyper-
tensive patients (67 males, 23 females; mean age 51.4 6 6.2 years)
without other concomitant diseases and/or cardiovascular risk factors.
Hypertensive patients were divided in high renin (N 5 30), normal
renin (N 5 30), and low renin (N 5 30) patients according to individual
pine PRA values at the end of a three-week period onplasma renin activity on a 120 mmol NaCl intake. In each group, the
horizontal line represents the mean and vertical line the sd of urinary a constant sodium intake (120 mmol NaCl per day). LR
albumin levels (*P , 0.02 vs. normal renin; §P , 0.01 vs. low renin). patients had the lowest, NR patients the intermediate,
and HR patients the highest PRA values. Interestingly,
the UAER was higher in HR than NR and LR patients,
whereas no differences were found between these twoshowed that diastolic pressure significantly influenced
latter subgroups. A significant correlation between circu-the UAER in all groups. According to this analysis, the
lating Ang II levels and UAER was also found. Thus,UAER correlated with diastolic blood pressure levels in
we suggest that an elevated renin system activity is com-all of the three patient groups (Fig. 4). Systolic blood
bined with early glomerular changes in essential hyper-pressure levels were directly correlated to the UAER in
tensive patients.HR (r 5 0.388, P 5 0.035) but not NR (r 5 0.016, P 5
Our study design’s premise was the known role of the0.437) and LR patients (r 5 0.002, P 5 0.548).
renin-angiotensin system in the pathogenesis of renalOther variables, such as routine analysis including lipid
disease [1–10, 13–15]. This role is supported by clinicaland glucose levels, heart rate, body mass index, and body
and experimental data, as well by the renoprotectiveweight, did not significantly affect the UAER.
actions exerted by ACE inhibitors [2, 3, 6, 8, 9, 19, 20] and
Ang II receptor antagonists [10–12] in macroproteinuric
DISCUSSION hypertensive as well as microproteinuric and macropro-
teinuric diabetic patients. In spite of this, correlationsIn this study, nondiabetic, nonobese essential hyper-
tensives were divided in three subgroups (namely, LR, between PRA and UAER have not been previously eval-
uated in essential hypertensives. Thus, our study repre-NR, and HR subgroups) on the basis of individual, su-
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hypertension-related glomerular changes caused by
higher Ang II concentrations. The fact that essential
hypertensive patients with a high renin profile should
be preferentially treated with ACE inhibitors has been
pointed out in the past [32], as well as in a recent review
[33]. Moreover, a high renin-sodium profile is known to
be associated with an increased prevalence of coronary
heart disease [34], a condition that is known to be more
frequent in microalbuminuric than normoalbuminuric
hypertensives [35]. Finally, a recent retrospective analy-
sis suggested that microalbuminuria precedes the decline
of renal function not only in diabetic individuals, but also
in nondiabetic hypertensives with a normal creatinine
clearance at baseline [22].
With regard to possible study limitations, the UAER
is known to be influenced by several factors [16]. To
avoid all possible confounders [16, 36], we studied only
middle-aged patients without obesity, diabetes, hyperlip-
idemia, and urinary tract infections. To exclude sponta-
neous variability of the UAER, measurements in our
patients included three consecutive 24-hour urine collec-
tions performed on the last three days of a three-week
period of them on a weight-maintaining diet. To exclude
PRA changes because of different NaCl intakes, NaCl
was maintained at an identical level in all patients. Fur-
thermore, it was controlled by repeated 24-hour NaCl
excretion. Since blood pressure levels are known to
strongly influence UAER [2, 16], diastolic blood pressure
levels correlated with the UAER in all patient groups.
However, all patient groups had similar blood pressure
levels. Thus, the correlation between blood pressure lev-
els and the UAER cannot explain the elevated UAER
observed in HR patients. The latter study limitation
could be found in the relationship between Ang II levels
and the UAER. Indeed, although significant (P 5 0.018),
such a correlation was quite low (r 5 0.43) in HR hyper-
tensives. In our opinion, this fact could be due to the
nonchromatographic methods available for plasma AngFig. 4. Relationship between diastolic blood pressure and urinary albu-
min excretion rate in 90 essential hypertensive patients (67 males, 23 II determination that poorly identify small differences
females; mean age 5 51.4 6 6.2 years) without other concomitant in the highest Ang II values [25]. Further, circulatingdiseases and/or cardiovascular risk factors, divided in high renin (N 5
Ang II interacts with other hormonal factors, such as30), normal renin (N 5 30), and low renin (N 5 30) patients according
to individual plasma renin activity on a 120 mmol NaCl intake. Signifi- atrial natriuretic peptide and aldosterone [30], which
cances are versus HR patients. have been suggested to favor the onset of earliest hyper-
tension-related renal changes [31, 37]. Unfortunately,
none of these hormones were evaluated in our patients,sents the first indication that a high renin profile is associ-
and we can only speculate on the matter. Similarly, weated with the earliest hypertension-related renal changes.
have no data on an individual ACE genotype, that is, anThe reasons leading to an elevated UAER in HR
inheritable factor that is known to influence both circulat-patients are probably related to the renal action of Ang
ing Ang II levels and the progression of renal damage [3].II. Indeed, Ang II promotes efferent vasoconstriction
In conclusion, our study demonstrates a higher UAERand mesangial cell contraction [6, 7, 27–29], thus favoring
in HR than NR and LR essential hypertensive patientsthe progressive appearance of microalbuminuria [2].
without concomitant diseases and/or risk factors otherFurthermore, Ang II stimulates atrial natriuretic peptide
than hypertension. This finding suggests that a high PRAsecretion and the consequent increment in protein excre-
is combined to early renal changes in mild-to-moderatetion [30, 31]. Therefore, it does not seem arbitrary to
suggest that an elevated PRA is combined with early essential hypertensive patients. Whether or not a high
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